{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:50:44Z","timestamp":1791352244053,"version":"4.3.1"},"reference-count":42,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Novartis Pharmaceuticals Corporation"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anticancer Therapy"],"DOI":"10.1080\/14737140.2026.2738626","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:55:59Z","timestamp":1791287759000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Real-world clinical and economic outcomes in chemotherapy-na\u00efve patients with metastatic castration-resistant prostate cancer"],"prefix":"10.1080","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0581-7963","authenticated-orcid":false,"given":"Rana R.","family":"McKay","sequence":"first","affiliation":[{"name":"UC San Diego","place":["San Diego, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation","place":["East Hanover, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barinder","family":"Kang","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation","place":["East Hanover, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Byrne","sequence":"additional","affiliation":[{"name":"Asclepius Analytics","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Tang","sequence":"additional","affiliation":[{"name":"Asclepius Analytics","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Runeckles","sequence":"additional","affiliation":[{"name":"Asclepius Analytics","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Sawhney","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation","place":["East Hanover, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeetvan","family":"Patel","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation","place":["East Hanover, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"e_1_3_6_2_1","unstructured":"Seer cancer stat facts: prostate cancer. Bethesda (MD) USA: National Cancer Institute; [cited 2025 May 14]. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/prost.html"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15245883"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpor.2015.06.006"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.10167"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2016.08.018"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-023-00725-8"},{"key":"e_1_3_6_8_1","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines\u00ae) - prostate cancer (Version 2.2025). 2025. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2016.10.008"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014618"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.07.032"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209096"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1207506"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001294"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61389-X"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71205-7"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1213755"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70379-0"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113467"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00906-z"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.6_suppl.64"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2021.100761"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8081251"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2021.1879753"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02572-4"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2019.12.019"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.e17024"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2026.2656539"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2026.102519"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2026.44.7_suppl.198"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911440"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00683-X"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8921"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00237-3"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15101292"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.183194"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2008.05.002"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1021\/cr500171e"},{"key":"e_1_3_6_40_1","unstructured":"PLUVICTO\u00ae (lutetium Lu 177 vipivotide tetraxetan) [Prescribing information]. East Hanover (NJ) USA: Novartis Pharmaceuticals Corporation; 2025 [cited 2025 May 16]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/215833s021s024lbl.pdf"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01653-2"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.4_suppl.186"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2026.20750"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2026.2738626","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14737140.2026.2738626","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2026.2738626","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:13:12Z","timestamp":1791349992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737140.2026.2738626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":42,"alternative-id":["10.1080\/14737140.2026.2738626"],"URL":"https:\/\/doi.org\/10.1080\/14737140.2026.2738626","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-06-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}